Showing results (51-60 of 140) with videos related to

Sort By:
Pageof 14
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 13, 2000
Treatment of bleeding episodes in patients with hemophilia and an inhibitor: comparison of two treatment protocols with recombinant activated factor VIIG Kenet, A Lubetsky, S Gitel, et al.
British Journal of Haematology|April 12, 2001
Transient adhesion refractoriness of circulating platelets under shear stress: the role of partial activation and microaggregate formation by suboptimal ADP concentrationN Savion, B Shenkman, I Tamarin, et al.
Physiological Research|August 28, 2001
Dispersion of cell-to-cell uncoupling precedes low K+-induced ventricular fibrillationN Tribulová, M Manoach, D Varon, et al.
Thrombosis and Haemostasis|September 1, 1994
High versus ultra-high purity factor VIII concentrate therapy: prospective evaluation of immunological and clinical parameters in HIV seronegative and seropositive hemophiliacsD Varon, S Schulman, R Dardik, et al.
European Journal of Internal Medicine|December 7, 2016
Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia veraA Rottenstreich, G Kleinstern, S Krichevsky, et al.
Israel Journal of Medical Sciences|October 1, 1991
The prevalence and interaction of human immunodeficiency virus and hepatitis B virus infections in Israeli hemophiliacsB Brenner, S Schwartz, E Ben-Porath, et al.
Journal of Basic and Clinical Physiology and Pharmacology|October 1, 1993
The defibrillating effect of catecholamine reuptake inhibitorsL Falkin, D Varon, M Erez, et al.
Clinical Neuropathology|November 1, 1990
Effects of various drugs on denervation changes in rat musclesJ Schwartz, L Rath-Wolfson, D Varon, et al.
Journal of Basic and Clinical Physiology and Pharmacology|October 1, 1993
Ethmozine and ethacizine--new antiarrhythmic drugs with defibrillating propertiesD Varon, M Rechavi, M Erez, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 3, 2009
Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitorsG Kenet, A Lubetsky, J Luboshitz, et al.
Pageof 14